H-1B Filings
22
Major sponsor. DOL labor condition applications on file.
Novo Nordisk, Inc. in NJ (Management of Companies) shows all three federal tracks on this profile: 22 H-1B LCAs, an employer OSHA injury record, and 1 WARN notice.
Novo Nordisk, Inc. (NJ): · 22 H-1B LCAs at a $175,000 disclosed median · OSHA Grade B (DART 0.25) · 1 WARN notice
According to DOL OFLC H-1B disclosures, OSHA ITA injury logs, and state WARN Act notices, Novo Nordisk, Inc. in NJ carries 22 H-1B wage filings on record, a $175,000 median wage across 20 disclosed-wage positions (above the $124,488 national median), a solid B OSHA safety grade and 1 WARN layoff notice on file. Every figure is a federal filing, not an estimate; see methodology for coverage limits.
Layoff & federal record
Compared with the rest of PlainEmployers' federal employer corpus, H-1B filing volume ranks #2,332 of 51,370 sponsors in this corpus (about the 95th percentile), and disclosed median wage sits at the 81st percentile of 272,125 credible H-1B wage rows.
Figures above come from DOL H-1B LCAs, this employer's OSHA injury log, and state WARN notices, three independent disclosure systems.
A weighted composite of DOL H-1B sponsorship and pay, OSHA establishment injury records, and WARN Act layoff notices, not culture, benefits, or "is this a good place to work." Missing tracks drop out and their weight redistributes so sparse records are not silently deflated.
Weights (redistributed when a track is N/A): Sponsorship scale (H-1B volume) 15% · Disclosed pay (H-1B wage percentile) 25% · Workplace safety (OSHA DART percentile) 35% · Layoff stability (WARN percentile) 25%. Sources: DOL OFLC · OSHA ITA · state WARN filings.
DOL LCA release change
H-1B Filings
22
Major sponsor. DOL labor condition applications on file.
Median H-1B Salary
$175,000
Above national median. Across 20 disclosed positions
OSHA Safety Grade
Grade B · DART 0.25
Safer than industry average. vs 0.33 same 2-digit NAICS sector (OSHA ITA 2022–2023, hours-weighted)
WARN Workforce Impact
263 workers
Less stable than most peers. 1 WARN Act notice on file
Where Novo Nordisk, Inc.'s H-1B wage sits nationally
Median disclosed wage vs. all US employers with H-1B filings
$175,000 Top 19% higher than 81% of 272,125 US employers
Each bar is a $20K-wide band; taller bars hold more US employers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source DOL Office of Foreign Labor Certification, H-1B Disclosure Data · August 2026
Filing-count-weighted median across this employer's own disclosed H-1B positions (+0.8% year over year), not a company-wide raise, and not adjusted for role mix changes between years.
| Field | Value | Source |
|---|---|---|
| Employer Name | Novo Nordisk, Inc. | DOL OFLC / OSHA / WARN |
| Industry | Management of Companies | NAICS / DOL |
| State | NJ | U.S. Federal Records |
| H-1B Filings | 22 | DOL OFLC LCA Disclosure |
| H-1B Median Salary | $175,000 | DOL OFLC LCA Disclosure |
| OSHA Safety Grade | B | OSHA ITA |
| OSHA DART Rate | 0.25 | OSHA ITA Establishment Records |
| WARN Layoff Notices | 1 notice(s), 263 workers | WARN Act notices, state workforce agency originals (archival backstop: LayoffData.com) |
Novo Nordisk, Inc.'s values above reflect the most recent DOL Labor Condition Applications, OSHA Injury Tracking Application records, WARN Act notices on file for this employer in NJ (Management of Companies). In this corpus, H-1B filing volume ranks #2,332 of 51,370 sponsors in this corpus (about the 95th percentile); disclosed median wage sits at the 81st percentile of 272,125 credible H-1B wage rows; OSHA DART rate is safer than roughly 62% of 214,554 employers with an establishment injury record.
| Job Title | Median |
|---|---|
| Associate Director - Formulation Development | $205,956 |
| Associate Director, Rare Disease Research | $205,000 |
| Associate Director, Regulatory Affairs | $202,020 |
| Associate Dir., Forecasting Capabilities & Patient Analytics | $190,000 |
| PRINCIPAL APPLICATIONS ARCHITECT - MARKETING TECHNOLOGY | $186,018 |
| SR MGR - FINANCIAL APPLICATIONS | $179,437 |
| SR MGR - FORECASTING | $179,400 |
| SR PROJECT MGR - IT | $179,294 |
| Senior Manager - Data Science | $175,000 |
| Senior Manager - New Product Commercialization | $175,000 |
| Sr Architect, Solutions | $173,056 |
| Lead Systems Analyst | $170,105 |
| MGR - FORECASTING & PLANNING | $168,730 |
| Anaplan Model Builder | $165,000 |
| Senior Architect - Solutions | $162,000 |
| Manager - Forecasting & Planning | $161,720 |
| Manager, Trial Management | $150,617 |
| Associate Manager | $138,190 |
| Specialist - Regulatory Operations - Submissions | $115,000 |
| SR ASSOC - SAMPLE OPERATIONS SUPPORT | $105,060 |
| Associate Director - Quality Control | N/A |
WARN history dominates: 1 notice put this employer among the 97% with the heaviest layoff filings in the corpus.
Novo Nordisk, Inc. in NJ (Management of Companies) filed 22 H-1B labor condition applications, of which 20 disclose a usable wage figure at a $175,000 disclosed median — a top-tercile sponsorship footprint in this corpus.
FY2025 filings fell 69.2% from FY2024 (13 → 4).
Disclosed pay runs high: $175,000 median beats 81% of credible wage rows and sits above the $124,488 national median.
Novo Nordisk, Inc. is one of the rarer profiles carrying both sponsorship volume (22 H-1B LCAs) and WARN history (1 notice) in the same public record (Management of Companies) in NJ. Weigh those signals separately.
DART 0.3 tracks close to the 0.3 sector average (Grade B).
Novo Nordisk, Inc.'s DART rate (days away/restricted/transferred per 100 FTE) vs the hours-weighted 2-digit NAICS sector average from OSHA ITA 2022–2023 (Management of Companies).
Total reported injuries on file: 25.
Where Novo Nordisk, Inc. sits
Across the 61 Management of Companies sponsors in this corpus with both an H-1B filing count and a credible disclosed-wage median, Novo Nordisk, Inc. files more petitions than 58% of them and discloses a higher median wage than 90%, the high-volume, above-median pay quadrant. Filing volume is hiring scale, not pay; the axes are independent DOL OFLC disclosures (22 filings · $175,000 median here).
Each muted dot is one management of companies peer from a filings-stratified sample of 36; the brand marker is Novo Nordisk, Inc.. Source: DOL Office of Foreign Labor Certification H-1B LCA disclosures (credible wages recomputed from per-position filings, excluding parse errors above $500k).
Novo Nordisk, Inc.'s nearest H-1B-filing peers in Management of Companies (home state NJ). Each card links to that employer's federal-records profile.
Two federal-records peer sets for Novo Nordisk, Inc., both outside NJ so the neighborhoods are not the same-industry VsCard above.
Nearest injury-rate peers outside NJ (DART 0.25 here).
Peers are nearest-neighbor matches on disclosed filing counts and OSHA ITA DART rates; employers with fewer than 100 H-1B filings or fewer than 10 reported injuries are excluded from the comparison corpus.
| Notice Date | Workers |
|---|---|
| 2025-09-01 | 263 |
What to check before working with Novo Nordisk, Inc.
Novo Nordisk, Inc. needs a three-way read: H-1B pay (22 LCAs), safety (grade B), and WARN history (1 notice); none of those alone is the rating.
Novo Nordisk, Inc.'s figures are legally filed public records (DOL, OSHA, state WARN), not reviews or vendor estimates; a missing row is not proof the underlying activity never happened.
Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from OSHA and the DOL Wage and Hour Division. Consult a qualified professional before making decisions based on this data.
Among 272,125 credible H-1B wage rows in this corpus, Novo Nordisk, Inc.'s disclosed median of $175,000 sits at the 81st percentile (above the $124,488 national median). The chart above uses a COUNT-exact percentile (rows below this wage ÷ total), not an interpolated estimate.
Novo Nordisk, Inc. has 22 H-1B filings on record, ranking #2,332 of 51,370 sponsors in this corpus (about the 95th percentile by volume). Filing volume is a sponsorship signal, not a headcount or hiring-quality score.
Novo Nordisk, Inc. carries Grade B from its establishment injury record (25 injuries on file; DART 0.25). That DART rate is safer than roughly 62% of 214,554 employers with an injury record in this corpus. Grades compare DART against industry averages, see the Interpreting Safety Grades guide.
Yes - 1 WARN Act notice affecting about 263 workers appear in the state-agency corpus for this employer. WARN covers mass layoffs and plant closings that meet statutory thresholds; absence of notices is not a guarantee of stability.
Related guides: How OSHA safety grades are calculated · Using H-1B wage filings in salary negotiation
Read our methodology - how this data is sourced, computed, and verified.
This profile is rendered directly from DOL H-1B disclosure filings, OSHA Injury Tracking Application records and state WARN Act layoff notices, no number is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of August 2026.